- Neogen Corporation announces the retirement of James P. Tobin from its Board of Directors, effective May 31, 2025.
- Andrea Wainer is appointed to the Neogen Board, effective June 1, 2025.
- Wainer brings extensive experience in diagnostics and healthcare, enhancing Neogen's strategic direction.
Neogen Corporation (NEOG, Financial), a leading provider of food safety solutions, has announced a significant transition within its Board of Directors. James P. Tobin, who has served on the Board since 2016, will retire effective May 31, 2025. During his tenure, Tobin was instrumental in guiding the company through a period of growth and transformation, chairing the Governance and Sustainability Committee and participating in the Audit Committee.
Stepping into the role on June 1, 2025, Andrea Wainer will replace Tobin on the Board. Wainer brings over 25 years of experience in the diagnostics and healthcare industry, most recently serving as Executive Vice President, Rapid and Molecular Diagnostics at Abbott Laboratories. In addition to her new role at Neogen, Wainer also serves as a director at Analog Devices, Inc. (ADI), where she is a member of the Nominations and Governance Committee.
James C. Borel, Chair of Neogen’s Board of Directors, expressed gratitude for Tobin's contributions and enthusiasm for Wainer's addition. He emphasized Wainer's expertise in molecular diagnostics and her experience in public company governance as invaluable assets for advancing Neogen’s mission in global food safety.
For further details on Neogen’s Board of Directors, please visit their official website.
